|
|
|
Diabetes
Latest News of Galvus
Novartis to launch trial comparing Galvus and other oral anti-diabetic drugs
Novartis to launch trial comparing Galvus and other oral anti-diabetic drugs...
www.hemscott.com
Galvus - Quick Facts
...Galvus, a DPP-4 inhibitor, works through a novel mechanism of action targeting the pancreatic islet dysfunction that causes high blood sugar levels in people with type 2 diabetes. Galvus affects both pancreatic alpha and beta cells, leading to a reduction in sugar production from the liver together with an increase in production of insulin needed to keep blood sugar under control...
www.drugs.com
New drug application for Galvus® accepted for review by FDA
EAST HANOVER, NJ, March 30, 2006 – Novartis announced today that the new drug application (NDA) for Galvus® (vildagliptin, formerly LAF237) was accepted for standard review by the U.S. Food and Drug Administration (FDA). If approved, Galvus will provide a new, once-daily oral treatment option for people with type 2 diabetes. Submission for approval in Europe is on track to be completed later in 2006...
www.pharma.us.novartis.com
Novartis Unveils Further Impressive Efficacy Data For Galvus
Galvus(R) (vildagliptin), seeking to become a new once-daily oral treatment option for type 2 diabetes, has demonstrated impressive efficacy, especially in patients with poor glycemic control, as well as weight loss benefits in obese patients...
www.medicalnewstoday.com
|
|
|
|
|
|
|
Disclaimer
 |  
Home
Copyright (c) 2005 , www.drugalertlist.com
|